Bluejay Diagnostics (BJDX) Other Non Operating Income (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Other Non Operating Income of $731.0 for Q1 2026, up 26.25% sequentially from $579.0 in Q4 2025, and down 89.06% YoY from $6681.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Other Non Operating Income (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Other Non Operating Income for 7 years, with the latest figure at $731.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 89.06% year-over-year to $731.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1589.0 (down 97.39% YoY) and the FY2025 annual result came in at $7769.0, down 93.98% from the prior year.
- Other Non Operating Income grew to $731.0 in Q1 2026 per BJDX's latest filing, from $579.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $139729.0 in Q1 2023 and troughed at -$80918.0 in Q4 2023.
- A 5-year average of $25986.1 and a median of $8566.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income jumped 204.3% in 2022, then tumbled 1759.18% in 2023.
- Over 5 years, Other Non Operating Income stood at $4877.0 in 2022, then sank by 1759.18% to -$80918.0 in 2023, then soared by 118.23% to $14751.0 in 2024, then sank by 96.07% to $579.0 in 2025, then advanced by 26.25% to $731.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $731.0, $579.0, and $554.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 282.00 |
| Mar 31, 2026 | 731.00 |
| Dec 31, 2025 | 579.00 |
| Sep 30, 2025 | 554.00 |
| Jun 30, 2025 | -275.00 |
| Mar 31, 2025 | 6,681.00 |
| Dec 31, 2024 | 14,751.00 |
| Sep 30, 2024 | 8,566.00 |
| Jun 30, 2024 | 30,944.00 |
| Mar 31, 2024 | 69,549.00 |
| Dec 31, 2023 | -80,918.00 |
| Sep 30, 2023 | 43,235.00 |
| Jun 30, 2023 | 90,383.00 |
| Mar 31, 2023 | 139,729.00 |
| Dec 31, 2022 | 4,877.00 |
| Sep 30, 2022 | 60,406.00 |
| Dec 31, 2021 | -4,676.00 |
| Mar 31, 2021 | 6,111.00 |
| Dec 31, 2020 | 147,323.00 |
| Sep 30, 2020 | 4,344.00 |